»ó´Ü¿©¹é
±â»ç (Àüü 393°Ç)
[Drug Review] ·Î¼ö¹Ù½ºÅ¸Æ¾/¹ß»ç¸£Åº º¹ÇÕÁ¦, ȯÀÚƯ¼º µû¶ó ¸ÂÃãÄ¡·á °¡´É ÀÌ»óµ· ±âÀÚ 2018-09-04 15:11
[Interview] ´ç´¢º´ ȯÀÚ Ç÷¾Ð ½Å¼Ó¡¤°­·Â¡¤Áö¼Ó Á¶ÀýÇØ¾ß ÀÌ»óµ· ±âÀÚ 2018-08-01 11:44
[Sub Story] ´ç´¢º´ ȯÀÚ ÀûÁ¤±âÁØ Ç÷¾ÐÁ¶Àý ±Ç°í ÀÌ»óµ· ±âÀÚ 2018-08-01 11:34
[Deep in Guideline] °íÇ÷¾Ð Ä¡·á¿¡ º¸¼ö‧Áøº¸ ¾ø´Ù ´Ù¸¸ ȯÀÚ°¡ ÀÖÀ» »Ó ÀÌ»óµ· ±âÀÚ 2018-07-31 17:27
[Drug Review] ¸ðƼ¸®Åæ, ±â´É¼º º¯ºñ¿¡µµ À¯È¿ÇÑ È¿°ú Á¦½Ã ÀÓ¼¼Çü ±âÀÚ 2018-07-16 14:55
¶óÀÎ
[Sub Story] ´ëÇѼÒÈ­±â±â´É¼ºÁúȯ¡¤¿îµ¿ÇÐȸ 2017 IBS ÀÓ»óÁø·á °¡À̵å¶óÀÎ ÀÌ»óµ· ±âÀÚ 2018-07-16 14:51
[Conference Report] °íÇ÷¾Ð Ä¡·á·Î ¡®Ä¡¸Å ¿¹¹æ±æ¡¯ ¿¬´Ù ÀÌ»óµ· ±âÀÚ 2018-07-16 14:27
[Conference Report] Ŭ·Î´Ïµò, ÀúÇ×¼º °íÇ÷¾Ð 4Â÷ ¾àÁ¦·Î ¶°¿À¸¦±î ÀÌ»óµ· ±âÀÚ 2018-07-16 14:24
[Conference Report] Ç×°íÇ÷¾ÐÁ¦ ½ÃÀÛ ½Ã±â ¡®»¡¶óÁ®¡¯¡¦Ä¡·á ȯÀÚ ¡®33¸¸¸í¡¯ ¡è ÀÌ»óµ· ±âÀÚ 2018-07-16 14:23
[Cover Story] ¼­¾ç°ú´Â ´Ù¸¥ ¡®Çѱ¹ÀΡ¯ ½É±Ù°æ»öÁõ °ü¸®Àü·«À» ã¾Æ¶ó ÀÓ¼¼Çü ±âÀÚ 2018-06-08 09:50
¶óÀÎ
[Sub Story] Çѱ¹Àο¡°Ô ÀûÀýÇÑ ABC´Â? THE MOST 2018-06-07 19:08
[Interview] Çѱ¹ÀÎ ½É±Ù°æ»öÁõ¿¡ ¸Â´Â ¿¹¹æ¡¤Ä¡·áÀü·«¿¡ ´«µ¹·Á¾ß ÀÓ¼¼Çü ±âÀÚ 2018-06-07 18:30
[Late Breaking Studies] ÀÌ´Þºñ(Edarbi), °­·Â¡¤Áö¼Ó Ç÷¾Ð°­ÇÏ·Â Çѱ¹Àο¡¼­µµ È®ÀÎ ÀÌ»óµ· ±âÀÚ 2018-06-07 17:39
[Expert Opinion] °ü»óµ¿¸ÆÁúȯ ȯÀÚÀÇ ½ÉÇ÷°ü»ç°Ç ¿¹¹æÀ» À§ÇÑ Àü·« ÀÓ¼¼Çü ±âÀÚ 2018-06-07 17:11
[Conference Report] CVD-REAL KOREA °á°ú´Â? ÀÓ¼¼Çü ±âÀÚ 2018-06-07 16:53
¶óÀÎ
[Conference Report] ¾Ë¸®·ÎÄí¸¿, ACS ȯÀÚ¿¡¼­µµ ÇýÅÃÈ®ÀÎ ÀÓ¼¼Çü ±âÀÚ 2018-06-07 16:50
[Conference Report] Ç׾Ͽä¹ýÀ¸·Î ÀÎÇÑ ½ÉÀ嵶¼º, Ç×°íÇ÷¾ÐÁ¦·Î ¸·À» ¼ö ÀÖ³ª ÀÓ¼¼Çü ±âÀÚ 2018-06-07 16:15
[Sub Story] ACC¡¤AHA, ³ëÀÎ ¼öÃà±âÇ÷¾Ð 130mmHg ¹Ì¸¸Á¶Àý ÆÄ°Ý ±Ç°í ÀÌ»óµ· ±âÀÚ 2018-05-03 15:04
[Deep in Guideline] Àü±â´ç´¢º´ºÎÅÍ ASCVD À§ÇèÀÎÀÚ °ü¸® °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2018-05-03 14:19
[Sub Story] ½ÉÇ÷°üÁúȯ ¿¹¹æ À§ÇØ µ¿¹Ý À§ÇèÀÎÀÚ °ü¸®Àü·« Á¦½Ã ÀÌ»óµ· ±âÀÚ 2018-04-03 17:10
Back to Top